Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

11-18-2010, 01:33 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,987	Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c Exelixis, Inc. today reported interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT). More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 08:06 PM.

free webpage hit counter